Chemours Co — Director's Dealing 2015

Jul 7, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2015-07-01

Reporting Person: Siemer Christian W (Pres. - Chemical Solutions)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-01	Common Stock, par value $.01	A	10311	$0.00	Acquired	10743	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-01	Stock Option (Right to Buy)	$12.9726	A	15088	Acquired	2018-02-01	Common Stock (15088)	Direct
2015-07-01	Stock Option (Right to Buy)	$12.9551	A	17909	Acquired	2019-02-05	Common Stock (17909)	Direct
2015-07-01	Stock Option (Right to Buy)	$11.8693	A	28082	Acquired	2020-02-05	Common Stock (28082)	Direct
2015-07-01	Stock Option (Right to Buy)	$15.4871	A	23373	Acquired	2021-02-04	Common Stock (23373)	Direct
2015-07-01	Stock Option (Right to Buy)	$18.4494	A	28429	Acquired	2022-02-03	Common Stock (28429)	Direct

Footnotes

F1: Represents restricted stock units granted in accordance with the Employee Matters Agreement (the "Agreement") dated as of June 26, 2015 between the Issuer and E. I. du Pont de Nemours and Company ("DuPont") to replace restricted stock units and related dividend equivalent units of DuPont held by the Reporting Person immediately before the legal and structural separation of Issuer from DuPont (the "Spin-off").

F2: Includes shares of Issuer common stock received in connection with the Spin-off in an exempt transaction pursuant to Rule 16a-9 based on preliminary information regarding the Spin-off. Final amounts, if different, will be reported in a subsequent filing.

F3: Award replaces stock options of DuPont held by the Reporting Person immediately before the Spin-off pursuant to the Agreement. Information reported in this row is estimated as of July 6, 2015 based on preliminary information regarding the Spinoff. Final information, if different, will be reported in a subsequent filing.

F4: Includes 18,721 options to purchase shares of Issuer common stock that are immediately exercisable. The remaining options vest on February 6, 2016.

F5: Includes 7,791 options to purchase shares of Issuer common stock that are immediately exercisable. The remaining options vest in two equal annual installments beginning February 5, 2016.

F6: Options to purchase shares of Issuer common stock vest in three approximately equal annual installments beginning February 4, 2016.